�MUMBAI, Dec 9: Biocon said that it has received its shareholders' approval to the resolution for transfer of biosimilars business by way of a slump sale to group entity Biocon Biologics India.��� The resolution for transfer of Biosimilars business of the company by way of a slump sale as 'Going Concern' to Biocon Biologics India has been passed by the members of the company with requisite majority.��� The special resolution was passed with 99.99 per cent of votes polled through postal ballot. Biocon is India's largest� leading Biotechnology Company with a strategic focus on biopharmaceuticals and research services.�� (UNI)
Advertisement

